Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.43 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.43 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.43 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.43 |
| ▸ | P2RY6 | Q15077 | 9/20 | 0.36 |
| ▸ | P2RY14 | Q15391 | 4/20 | 0.33 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.32 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.31 |
| ▸ | TK1 | P04183 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL629554 | 0.91 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL27528956 | 0.91 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL5004102 | 0.91 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL15414027 | 0.89 | SLC28A1 (0.39) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL29777381 | 0.89 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL1009600 | 0.89 | SLC28A1 (0.40) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL8098949 | 0.87 | SLC28A1 (0.43) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL8170876 | 0.87 | SLC28A1 (0.43) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL8763033 | 0.82 | SLC28A1 (0.34) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL8763022 | 0.82 | SLC28A1 (0.34) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0101441-B1 | ANTI-VIRAL COMPOSITIONS | SYNTEX (U.S.A.) INC. (US) | 1987-01-14 | — | — | EP | claimed |
| EP-0101441-A4 | ANTI-VIRAL COMPOSITIONS. | ENS BIO LOGICALS INC (CA) | 1985-04-11 | — | — | EP | claimed |
| EP-0101441-A1 | ANTI-VIRAL COMPOSITIONS. | ENS BIO LOGICALS INC (CA) | 1984-02-29 | — | — | EP | claimed |
| WO-1983002723-A1 | ANTI-VIRAL COMPOSITIONS | SMITH, KENDALL, O. | 1983-08-18 | — | — | WO | claimed |
| US-20060223775-A1 | Nucleotide sequence for treating cancer and infection | ZEICHER MARC | 2006-10-05 | — | — | US | disclosed |
| EP-0673430-A1 | NUCLEOTIDE SEQUENCE FOR TREATING CANCER AND INFECTION | Z. COMPANY S.A. (BE) | 1995-09-27 | — | — | EP | disclosed |
| WO-1994013823-A1 | NUCLEOTIDE SEQUENCE FOR TREATING CANCER AND INFECTION | Z. COMPANY S.A. (BE) | 1994-06-23 | — | — | WO | disclosed |